On April 15, the FDA conducted an inspection at Evolution Devices, Inc. in San Francisco, resulting in seven citations related to device compliance and post-market assurance.
Medicaid expenditures for the Medical And Surgical Supplies category in San Francisco grew by 1.1% in 2024, signaling shifts in use and payment trends.
San Francisco saw a 98.7% rise in Medicaid payments linked to the Anesthesia category in 2024, highlighting shifts in service usage and reimbursement.
San Mateo’s Medicaid payments for Evaluation and Management services climbed by 19.5% in 2024, signaling shifts in service use and payment practices.
In 2024, Medicaid providers in San Francisco submitted $6,619,911 in claims categorized as Surgery services, representing a 150.5% rise from the prior year.
UCSF Assistant Professor Anthony DiGiorgio said on May 13 that the federal 340B program disadvantages independent oncology practices by giving large hospital systems access to steeply discounted drugs.
Medicaid payments for the Procedures / Professional Services category in San Francisco surged 58.7% in 2024, highlighting shifts in service use and reimbursement trends.
Southeast Asian Food Product, Inc. in San Francisco underwent an FDA inspection on Feb. 20 focused on labeling, standards, food composition, and foodborne biological hazards, resulting in five cited violations.
The FDA conducted an inspection at Shun Lee, Inc. in San Francisco on April 23 focused on foodborne biological risks, according to agency records.
ICE identified Wilfredo Jose Tortolero-Arriechi as a Venezuelan national suspected in a fatal stabbing at Zuckerberg San Francisco General Hospital. Officials say he entered the U.S. illegally in 2023 before being released under federal policy.